EC Number   |
Disease   |
PubMed ID   |
Title of Publication   |
Category |
Confidence Level |
|---|
 1.1.99.5 | Acidosis |
16477389 |
Effects of lactate dehydrogenase suppression and glycerol-3-phosphate dehydrogenase overexpression on cellular metabolism. |
causal interaction |
1 |
 1.1.99.5 | Acidosis |
16477389 |
Effects of lactate dehydrogenase suppression and glycerol-3-phosphate dehydrogenase overexpression on cellular metabolism. |
unassigned |
0 |
 1.1.99.5 | Carcinoma, Hepatocellular |
6296163 |
Glycerol-3-phosphate dehydrogenase is induced by glucocorticoids in hepatocytes and hepatoma cells in vitro. |
therapeutic application |
1 |
 1.1.99.5 | Carcinoma, Hepatocellular |
6296163 |
Glycerol-3-phosphate dehydrogenase is induced by glucocorticoids in hepatocytes and hepatoma cells in vitro. |
ongoing research |
4 |
 1.1.99.5 | Carcinoma, Hepatocellular |
6296163 |
Glycerol-3-phosphate dehydrogenase is induced by glucocorticoids in hepatocytes and hepatoma cells in vitro. |
unassigned |
0 |
 1.1.99.5 | Diabetes Mellitus, Type 2 |
8866570 |
Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats. |
causal interaction |
1 |
 1.1.99.5 | Diabetes Mellitus, Type 2 |
30321069 |
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity. |
causal interaction |
3 |
 1.1.99.5 | Diabetes Mellitus, Type 2 |
8866570 |
Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats. |
diagnostic usage |
1 |
 1.1.99.5 | Diabetes Mellitus, Type 2 |
30321069 |
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity. |
therapeutic application |
1 |
 1.1.99.5 | Diabetes Mellitus, Type 2 |
32741295 |
PolyMet-HA nanocomplexs regulates glucose uptake by inhibiting SHIP2 activity. |
therapeutic application |
1 |